Byrd, J. C., Woyach, J. A., Furman, R. R., Martin, P., O’Brien, S., Brown, J. R., Stephens, D. M., Barrientos, J. C., Patten, P. E., Munir, T., Patel, K., Butturini, A., de Borja, M., Wang, M. H., Jain, N., & Wierda, W. G. (2022). Final Results of the Phase 1/2 Study of Acalabrutinib Monotherapy in Treatment-Naive Chronic Lymphocytic Leukemia with >6 Years of Follow-up. Blood, 140(Supplement 1), 9865–9867. https://doi.org/10.1182/blood-2022-159542